International Clinical Trial: An Early Feasibility Study of the BioJet™ Oral Biotherapeutic Delivery System for Administration of Therapeutic Agents in Healthy Participants

Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07849153) titled 'An Early Feasibility Study of the BioJet™ Oral Biotherapeutic Delivery System for Administration of Therapeutic Agents in Healthy Participants' on Sept. 24.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Biora Therapeutics, Inc.

Condition: Healthy Subjects

Intervention: Drug: Hadlima(R) Drug: Hadlima(R)

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: October 20, 2026

Target Sample Size: 30

To know more, visit https://clinicaltrials.gov/stud...